Literature DB >> 33482440

Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.

Pi-I D Lin1, Andres Cardenas2, Russ Hauser3, Diane R Gold4, Ken P Kleinman5, Marie-France Hivert6, Antonia M Calafat7, Thomas F Webster8, Edward S Horton9, Emily Oken10.   

Abstract

Per- and polyfluoroalkyl substances (PFAS) are ubiquitously detected in populations worldwide and may hinder kidney function. The objective of the study was to determine longitudinal associations of plasma PFAS concentrations with estimated glomerular filtration rate (eGFR) and evaluate whether a lifestyle intervention modify the associations. We studied 875 participants initially randomized to the lifestyle or placebo arms in the Diabetes Prevention Program (DPP, 1996-2002) trial and Outcomes Study (DPPOS, 2002-2014). We ran generalized linear mixed models accounting a priori covariates to evaluate the associations between baseline PFAS concentrations and repeated measures of eGFR, separately, for six PFAS (PFOS, PFOA, PFHxS, EtFOSAA, MeFOSAA, PFNA); then used quantile-based g-computation to evaluate the effects of the six PFAS chemicals as a mixture. The cohort was 64.9% female; 73.4% 40-64 years-old; 29.4% with hypertension; 50.5% randomized to lifestyle intervention and 49.5% to placebo and had similar plasma PFAS concentrations as the general U.S. population in 1999-2000. Most participants had normal kidney function (eGFR > 90 mL/min/1.73 m2) over the approximately 14 years of follow-up. We found that plasma PFAS concentrations during DPP were inversely associated with eGFR during DPPOS follow-up. Each quartile increase in baseline plasma concentration of the 6 PFAS as a mixture was associated with 2.26 mL/min/1.73 m2 lower eGFR (95% CI: -4.12, -0.39) at DPPOS Year 5, approximately 9 years since DPP randomization and PFAS measurements. The lifestyle intervention did not modify associations, but inverse associations were stronger among participants with hypertension at baseline. Among prediabetic adults, we found inverse associations between baseline plasma PFAS concentrations and measures of eGFR throughout 14 years of follow-up. The lifestyle intervention of diet, exercise and behavioral changes did not modify the associations, but persons with hypertension may have heightened susceptibility.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diabetes Prevention Program; Hypertension; Kidney function; Per- and polyfluoroalkyl substances; Prediabetic adults; eGFR

Mesh:

Substances:

Year:  2021        PMID: 33482440      PMCID: PMC7929640          DOI: 10.1016/j.envint.2020.106375

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  48 in total

1.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

2.  Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma.

Authors:  Martin Forsthuber; Andreas Marius Kaiser; Sebastian Granitzer; Ingrid Hassl; Markus Hengstschläger; Herbert Stangl; Claudia Gundacker
Journal:  Environ Int       Date:  2020-02-25       Impact factor: 9.621

3.  Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.

Authors:  Ronald B Goldberg; Vanita R Aroda; David A Bluemke; Elizabeth Barrett-Connor; Matthew Budoff; Jill P Crandall; Dana Dabelea; Edward S Horton; Kieren J Mather; Trevor J Orchard; David Schade; Karol Watson; Marinella Temprosa
Journal:  Circulation       Date:  2017-05-05       Impact factor: 29.690

4.  Human Exposure and Elimination Kinetics of Chlorinated Polyfluoroalkyl Ether Sulfonic Acids (Cl-PFESAs).

Authors:  Yali Shi; Robin Vestergren; Lin Xu; Zhen Zhou; Chuangxiu Li; Yong Liang; Yaqi Cai
Journal:  Environ Sci Technol       Date:  2016-02-11       Impact factor: 9.028

5.  Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008.

Authors:  Kayoko Kato; Lee-Yang Wong; Lily T Jia; Zsuzsanna Kuklenyik; Antonia M Calafat
Journal:  Environ Sci Technol       Date:  2011-04-06       Impact factor: 9.028

6.  Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals.

Authors:  Kayoko Kato; Brian J Basden; Larry L Needham; Antonia M Calafat
Journal:  J Chromatogr A       Date:  2010-10-21       Impact factor: 4.759

Review 7.  Microalbuminuria in hypertension.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

8.  Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Marco Sanchez-Guerra; Citlalli Osorio-Yáñez; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2020-02-18       Impact factor: 9.621

Review 9.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

10.  A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.

Authors:  Radhika Dhingra; Andrea Winquist; Lyndsey A Darrow; Mitchel Klein; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2016-08-16       Impact factor: 9.031

View more
  3 in total

Review 1.  Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk.

Authors:  Katherine Roth; Michael C Petriello
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

2.  The Role of Ferroptosis in the Damage of Human Proximal Tubule Epithelial Cells Caused by Perfluorooctane Sulfonate.

Authors:  Pingwei Wang; Dongge Liu; Shuqi Yan; Yujun Liang; Jiajing Cui; Li Guo; Shuping Ren; Peng Chen
Journal:  Toxics       Date:  2022-07-29

3.  How do environmental characteristics jointly contribute to cardiometabolic health? A quantile g-computation mixture analysis.

Authors:  Noémie Letellier; Steven Zamora; Jiue-An Yang; Dorothy D Sears; Marta M Jankowska; Tarik Benmarhnia
Journal:  Prev Med Rep       Date:  2022-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.